EASY BIO,Inc. (353810.KQ)
KRW 4570.0
(0.44%)
KRW 4570.0
(0.44%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 20.63 Billion KRW | 27.72% |
| 2022 | 16.15 Billion KRW | -3.73% |
| 2021 | 16.77 Billion KRW | 10.41% |
| 2020 | 15.19 Billion KRW | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 8.43 Billion KRW | 54.71% |
| 2024 Q1 | 6.29 Billion KRW | 27.93% |
| 2023 Q1 | 4.77 Billion KRW | 31.67% |
| 2023 FY | 20.63 Billion KRW | 27.72% |
| 2023 Q4 | 4.92 Billion KRW | -15.24% |
| 2023 Q3 | 5.8 Billion KRW | 13.28% |
| 2023 Q2 | 5.12 Billion KRW | 7.36% |
| 2022 FY | 16.15 Billion KRW | -3.73% |
| 2022 Q3 | 4.52 Billion KRW | 7.21% |
| 2022 Q4 | 3.62 Billion KRW | -19.88% |
| 2022 Q2 | 4.22 Billion KRW | 11.71% |
| 2022 Q1 | 3.77 Billion KRW | 6.86% |
| 2021 Q1 | 4.76 Billion KRW | 7.31% |
| 2021 FY | 16.77 Billion KRW | 10.41% |
| 2021 Q4 | 3.53 Billion KRW | -18.28% |
| 2021 Q3 | 4.32 Billion KRW | 4.16% |
| 2021 Q2 | 4.15 Billion KRW | -12.72% |
| 2020 FY | 15.19 Billion KRW | 0.0% |
| 2020 Q4 | 4.43 Billion KRW | -35.23% |
| 2020 Q3 | 6.84 Billion KRW | 75.0% |
| 2020 Q2 | 3.91 Billion KRW | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| HLB Co., Ltd. | -125.02 Billion KRW | 116.502% |
| iNtRON Biotechnology, Inc. | -3.28 Billion KRW | 728.051% |
| BINEX Co., Ltd. | 1.04 Billion KRW | -1879.463% |
| Bioneer Corporation | 791.75 Million KRW | -2505.765% |
| Anterogen.Co.,Ltd. | -5.07 Billion KRW | 506.619% |
| MEDIPOST Co., Ltd. | -25.13 Billion KRW | 182.096% |
| CrystalGenomics, Inc. | -30.91 Billion KRW | 166.74% |
| Helixmith Co., Ltd | -35.24 Billion KRW | 158.536% |
| Chabiotech Co.,Ltd. | -9.42 Billion KRW | 318.894% |
| Medy-Tox Inc. | 17.32 Billion KRW | -19.102% |
| Peptron, Inc. | -15.6 Billion KRW | 232.227% |
| Amicogen, Inc. | 2.05 Billion KRW | -903.395% |
| Genexine, Inc. | -41.24 Billion KRW | 150.026% |
| HLB Therapeutics Co.,Ltd. | -8.7 Billion KRW | 337.133% |
| LegoChem Biosciences, Inc. | -80.82 Billion KRW | 125.527% |
| ALTEOGEN Inc. | -9.73 Billion KRW | 311.888% |
| PharmaResearch Co., Ltd. | 100.81 Billion KRW | 79.536% |
| SillaJen, Inc. | -21.34 Billion KRW | 196.652% |
| JETEMA, Co., Ltd. | 2.63 Billion KRW | -683.373% |
| OliX Pharmaceuticals,Inc | -18.18 Billion KRW | 213.45% |
| Genomictree Inc. | -17.3 Billion KRW | 219.232% |
| MedPacto, Inc. | -28.75 Billion KRW | 171.756% |
| D&D Pharmatech | -13.48 Billion KRW | 252.98% |
| GI Innovation, Inc. | -55.6 Billion KRW | 137.104% |